These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11191722)

  • 1. Clinical study of cefpirome sulphate in obstetric and gynaecological infections.
    Sagawa T; Fuiuno T; Sakuragi N; Kishida T; Yamada H; Fuiimoto S
    J Int Med Res; 2000; 28(6):288-99. PubMed ID: 11191722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefpirome sulphate for gynaecological infections and prophylaxis of non-laparotomy surgery in patients with benign disease.
    Hayashi H; Yamashita T; Nakata T; Huji T; Kojima T; Katayama H; Ishikawa M
    Int J Antimicrob Agents; 2002 May; 19(5):405-11. PubMed ID: 12007849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy of cefpirome sulfate against Bacteroides species, Prevotella species and Porphyromonas species. Society of Anaerobic Bacterial Infections in the fields of obstetrics and gynecology in Gifu].
    Mikamo H; Sato Y; Hayasaki Y; Hua YX; Tamaya T; Iwasa S; Kawazoe K; Furuta N; Ito M; Nomura M; Tsukahara Y; Furui K; Sakakibara K; Hattori S; Sugiyama M; Ohnishi N; Hirose R; Nakagawa M; Yamada Y; Hashiyama T; Arahori K; Izumi K; Shiraki S; Morishita S; Watanabe K
    Jpn J Antibiot; 2000 Jan; 53(1):26-45. PubMed ID: 10709144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies on cefpiramide in the field of obstetrics and gynecology].
    Tateno M; Kitagawa Y
    Jpn J Antibiot; 1985 Aug; 38(8):2367-73. PubMed ID: 4079010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of cefotaxime in the treatment of obstetric and gynaecological infections.
    Soutoul JH; Quentin R; Boscq G; Chazara C; Prieur D
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():283-5. PubMed ID: 6252172
    [No Abstract]   [Full Text] [Related]  

  • 6. Worldwide clinical experience with cefoperazone.
    Gerber AU; Craig WA
    Drugs; 1981; 22 Suppl 1():108-18. PubMed ID: 6456884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited-spectrum (first-generation) cephalosporins.
    Graham JM; Oshiro BT; Blanco JD
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):449-59. PubMed ID: 1436923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cephalosporins.
    Martens MG
    Obstet Gynecol Clin North Am; 1989 Jun; 16(2):291-304. PubMed ID: 2674797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous cefoxitin sodium for the treatment of infections in obstetric and gynaecological patients.
    Galask RP; Ohm M
    J Antimicrob Chemother; 1978 Jul; 4(B):241-3. PubMed ID: 690024
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of expanded spectrum cephalosporins for the treatment of obstetrical and gynecological infections.
    Mercer LJ
    Obstet Gynecol Surv; 1988 Sep; 43(9):569-75. PubMed ID: 3145476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical studies of flomoxef in the field of obstetrics and gynecology. Representative Committee Members of the Research Team for Infections in the Field of Obstetrics and Gynecology].
    Matsuda S; Okada H; Ninomiya K; Shimizu T; Noda K; Deguchi K
    Jpn J Antibiot; 1988 Dec; 41(12):1822-40. PubMed ID: 3074181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study of cefpimizole in obstetric and gynecologic infections.
    Sugiyama T; Miyahara K; Kato T
    Jpn J Antibiot; 1985 Apr; 38(4):1017-21. PubMed ID: 4032718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of intravenous cefoxitin sodium in patients with obstetric/gynaecologic infections.
    White JS; Gee C; Ledger WJ
    J Antimicrob Chemother; 1978 Jul; 4(B):239-40. PubMed ID: 357395
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fundamental and clinical studies on cefpimizole in the field of obstetrics and gynecology].
    Yamamoto T; Yasuda J; Tomioka M; Kanao M; Okada H
    Jpn J Antibiot; 1985 Apr; 38(4):987-94. PubMed ID: 4032735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of cefpirome in the treatment of complicated infections of the upper and lower urinary tracts].
    Derevianko II; Kotliarova GA; Kondrat'eva EM; Khodyreva LA; Siniukhin VN
    Antibiot Khimioter; 1996; 41(12):30-3. PubMed ID: 9124983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cephamycins in obstetrics and gynecology.
    Sweet RL
    J Reprod Med; 1990 Nov; 35(11 Suppl):1064-9. PubMed ID: 2277374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fundamental and clinical studies on cefpimizole in the field of obstetrics and gynecology].
    Yamamoto K; Uchida K; Eguchi F; Shirakawa K
    Jpn J Antibiot; 1985 Apr; 38(4):1011-6. PubMed ID: 4032717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-spectrum (second- and third-generation) cephalosporins.
    Eriksen NL; Blanco JD
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):461-74. PubMed ID: 1436924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefoperazone therapy for obstetric and gynecologic infections.
    Strausbaugh LJ; Llorens AS
    Rev Infect Dis; 1983; 5 Suppl 1():S154-60. PubMed ID: 6221385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic activities of cefpirome against fresh clinical isolates resistant to multiple drugs].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1994 Feb; 47(2):143-60. PubMed ID: 8151908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.